Endocrinology

Help Shape the Future of Denosumab Treatment

As biosimilars enter the denosumab landscape, your perspective as a healthcare provider is critical in understanding what factors influence treatment decisions. This brief survey explores your views on reimbursement considerations, coding challenges, switching comfort, and drivers of biosimilar choice. As a thank you, by completing the survey, you’ll be entered into a drawing for a chance to win a $200 gift card.

Take the survey now and make your voice heard

Latest News

 Large National Claims Analysis Underscores Gap Between CGM Eligibility and Real-World Use in Diabetes Care / image credit ©yurii/stock.adobe.com
Large National Claims Analysis Underscores Gap Between CGM Eligibility and Real-World Use in Diabetes Care

December 15th 2025

CGM users experienced fewer ED and inpatient days and better glycemic outcomes, but most eligible adults in this large cohort did not use the technology.

Perimenopause Misdiagnosis Remains Widespread as Clinicians Miss Hormonal Transition Explains Bruce Dorr, MD, URPS, IFM-CP
Perimenopause Misdiagnosis Remains Widespread as Clinicians Miss Hormonal Transition Explains Bruce Dorr, MD, URPS, IFM-CP

December 9th 2025

ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management / image credit Rita R Kalyani, MD, MHS   Courtesy of the American Diabetes Assocation
ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management

December 9th 2025

FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option / image credit ©Tada Images/stock.adobe.com
FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option

December 4th 2025

Obesity Linked to Faster Alzheimer’s Disease Progression in Longitudinal Blood Biomarker Analysis / image credit Cyrus Raji, MD, PhD  Courtesy of RSNA
Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis

December 2nd 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.